CD40L-HyperIgM Syndrome
1 clinical trials · Condition
◉ Watch CD40L-HyperIgM Syndrome
| Record | Firm | Date |
|---|---|---|
| Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study (NCT06959771) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-07-16 |
Track CD40L-HyperIgM Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.